PONTE VEDRA, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the ...
PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Treace Medical Concepts, Inc. Secures $50 Million Debt Facility and Expands Revolving Line of Credit
PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc. (“Treace”), a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announced that it ...
PONTE VEDRA, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Hosted on MSN
Treace Medical revises 2025 revenue guidance to $211M-$213M as demand shifts and new products expand market reach
Earnings Call Insights: Treace Medical Concepts, Inc. (TMCI) Q3 2025 John Treace, Founder, Chairman & CEO, reported third quarter revenues of $50.2 million, representing 11% growth over the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback